Mimedx (MDXG) Free Cash Flow Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -73.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.41% |
| Dec 31, 2025 | 26.85% |
| Sep 30, 2025 | 57.30% |
| Jun 30, 2025 | -37.10% |
| Mar 31, 2025 | 1.82% |
| Dec 31, 2024 | 135.18% |
| Sep 30, 2024 | 34.98% |
| Jun 30, 2024 | 202.82% |
| Mar 31, 2024 | 203.27% |
| Dec 31, 2023 | 127.82% |
| Sep 30, 2023 | 2,149.67% |
| Jun 30, 2023 | 320.86% |
| Mar 31, 2023 | 54.73% |
| Dec 31, 2022 | 131.71% |
| Sep 30, 2022 | -89.45% |
| Jun 30, 2022 | -383.50% |
| Mar 31, 2022 | -19.97% |
| Dec 31, 2021 | 7.83% |
| Sep 30, 2021 | 209.73% |
| Jun 30, 2021 | 134.05% |
| Mar 31, 2021 | 35.15% |
| Dec 31, 2020 | 47.85% |
| Sep 30, 2020 | -58.93% |
| Jun 30, 2020 | -286.64% |
| Mar 31, 2020 | 16.44% |
| Dec 31, 2019 | -7,974.24% |
| Sep 30, 2019 | -345.99% |
| Jun 30, 2019 | -89.69% |
| Mar 31, 2019 | -323.84% |
| Dec 31, 2018 | -101.49% |
| Sep 30, 2018 | -90.35% |
| Jun 30, 2018 | 35.16% |
| Mar 31, 2018 | -33.14% |
| Dec 31, 2017 | -0.82% |
| Sep 30, 2017 | 975.29% |
| Jun 30, 2017 | 143.59% |
| Mar 31, 2017 | 456.11% |
| Dec 31, 2016 | 635.67% |
| Sep 30, 2016 | -76.99% |
| Jun 30, 2016 | 213.13% |
| Mar 31, 2016 | -204.26% |
| Dec 31, 2015 | -53.50% |
| Sep 30, 2015 | -36.72% |
| Jun 30, 2015 | 53.52% |
| Mar 31, 2015 | 274.04% |
| Dec 31, 2014 | 108.34% |
| Sep 30, 2014 | 1,053.47% |
| Jun 30, 2014 | 166.35% |
| Mar 31, 2014 | 24.25% |
| Dec 31, 2013 | 352.44% |
| Sep 30, 2013 | 175.41% |
| Jun 30, 2013 | -215.77% |
| Mar 31, 2013 | -68.62% |
| Dec 31, 2012 | 48.36% |
| Sep 30, 2012 | -8.41% |
| Jun 30, 2012 | 74.58% |
| Mar 31, 2012 | 32.28% |